Resultats de la cerca - James F. Trotter
- Mostrar 1 - 20 resultats de 38
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation per John K. O’Connor, James F. Trotter, Gary L. Davis, Jane Dempster, Göran B. Klintmalm, Robert M. Goldstein
Publicat 2012Artigo -
10
-
11
Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal per Jeffrey Campsen, Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas H. Bak, Tracy Steinberg, Maria Kaplan, Franklin L. Wright, Igal Kam
Publicat 2008Artigo -
12
Outcomes of living donor liver transplantation for acute liver failure: The adult-to-adult living donor liver transplantation cohort study per Jeffrey Campsen, Andrés T. Blei, Jean C. Emond, James E. Everhart, Chris E. Freise, Anna S. Lok, Sammy Saab, Karen Wisniewski, James F. Trotter
Publicat 2008Artigo -
13
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation per Marcelo Kugelmas, Purnima Spiegelman, Michael J. Osgood, David A. Young, James F. Trotter, Tracy Steinberg, Michael Wachs, Thomas H. Bak, Igal Kam, Gregory T. Everson
Publicat 2003Artigo -
14
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: A multicenter cohort study per Jennifer C. Lai, Jacqueline G. O’Leary, James F. Trotter, Elizabeth C. Verna, Robert S. Brown, R. Todd Stravitz, Jeffrey D. Duman, Lisa Forman, Norah A. Terrault
Publicat 2012Artigo -
15
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma per Christian Toso, James F. Trotter, Alice C. Wei, David L. Bigam, Shimul A. Shah, Joshua Lancaster, David Grant, Paul D. Greig, A. M. James Shapiro, Norman M. Kneteman
Publicat 2008Artigo -
16
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates per Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, Steven Zacks, Kari E. Roberts, Vijay H. Shah, Neil Kaplowitz, Lisa Forman, Keith Wille, Steven M. Kawut
Publicat 2008Artigo -
17
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy per James R. Burton, Jacqueline G. O’Leary, Elizabeth C. Verna, Varun Saxena, Jennifer L. Dodge, Richard T. Stravitz, Joshua Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault
Publicat 2014Artigo -
18
Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men per Jennifer C. Lai, Elizabeth C. Verna, Robert S. Brown, Jacqueline G. O’Leary, James F. Trotter, Lisa Forman, Jeffrey D. Duman, Richard G. Foster, Todd R. Stravitz, Norah A. Terrault
Publicat 2011Artigo -
19
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis per Mary E. Rinella, James F. Trotter, Manal F. Abdelmalek, Angelo H. Paredes, Margery A. Connelly, Mark Jaros, Lei Ling, Stephen J. Rossi, Alex M. DePaoli, Stephen A. Harrison
Publicat 2018Artigo -
20
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation per James F. Trotter, Karen Wisniewski, Norah A. Terrault, James E. Everhart, Milan Kinkhabwala, Robert M. Weinrieb, Jeffrey H. Fair, Robert A. Fisher, Alan J. Koffron, Sammy Saab, Robert M. Merion
Publicat 2007Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Transplantation
Liver transplantation
Gastroenterology
Disease
Surgery
Liver disease
Cohort
Cirrhosis
Living donor liver transplantation
Pathology
Alternative medicine
Fatty liver
Intensive care medicine
Placebo
Fibrosis
Receptor
Steatohepatitis
Confidence interval
Donation
Immunosuppression
Physics
Primary sclerosing cholangitis
Tacrolimus
Agonist
Biology
Chronic liver disease
Clinical endpoint
Economic growth